Tag: Elanco: Page 2

Elanco reports strong results, raises 2021 outlook

Elanco Animal Health Inc. reported higher-than-expected results for the second quarter of 2021 and increased its full year revenue outlook.

August 9, 2021

Double Exposure Image Of Business Profit Growth

Elanco to sell 2 manufacturing sites, close another

Connecticut-based TriRx Pharmaceuticals will purchase the company’s sites in Shawnee, Kansas, and Speke, United Kingdom.

June 10, 2021

Terre Haute – Circa May 2020: Elanco Animal Health Location. Ela

Elanco adds Marcela Kirberger to its team

Marcela Kirberger joins Elanco as general counsel.

June 9, 2021

African Swine Fever

Swine, cattle segments boost Elanco’s Q1 revenue

Stabilization in U.S. swine and cattle and a strong recovery in China’s swine herd from African swine fever (ASF) contributed to Elanco’s strong financial results for the first quarter of 2021.

May 7, 2021

Elanco revenue up 45% in fourth quarter

Elanco Animal Health reported US$1.14 million in revenue for the fourth quarter of 2020, a 45% increase from the same period the previous year.

February 24, 2021

Double Exposure Image Of Business Profit Growth

Elanco to eliminate 350 jobs in further restructuring

Elanco Animal Health Inc. will eliminate 350 positions around the world as part of its next step of its restructuring to improve operational efficiency.

January 29, 2021

Elanco-antibiotics

Sarena Lin to leave Elanco Animal Health, join Bayer

Sarena Lin, who most recently served as executive vice president of transformation and technology at Elanco Animal Health, will leave the company and join Bayer AG as chief transformation and talent officer.

January 12, 2021

Elanco to establish consolidated headquarters in Indiana

Elanco Animal Health Inc. has selected Indiana as its base for future global consolidated operations, anchored by a new streamlined fit-for-purpose global headquarters in downtown Indianapolis

December 7, 2020

Elanco-antibiotics

Elanco Animal Health’s third quarter revenue up 15%

Total revenue for the period, which reflect the inclusion of Bayer Animal Health, which Elanco acquired on August 1, was US$889.6 million.

November 6, 2020

business-growth-profit-1605

China continues to review ban on ractopamine residues

As part of the Phase 1 trade deal with the U.S., China committed to review its ban on ractopamine residues in meat.

November 4, 2020

Fat Pigs And Sows Eat In Livestock Of The Farm

Elanco to restructure, eliminate 900 positions

Elanco Animal Health Inc. says it will restructure its business, eliminating hundreds of positions, and has started to deleverage by making a US$100 million payment on the loan that financed its acquisition of Bayer Animal Health.

September 30, 2020

Elanco-antibiotics

Elanco completes acquisition of Bayer Animal Health

Elanco Animal Health Inc. has completed its US$6.89 billion acquisition of Bayer Animal Health, the company said on Monday.

August 3, 2020

Elanco-antibiotics

Page 2 of 3